**not participating in webinar
Available via
WEBINAR
Innovative Vaccines against Resistant Infectious Diseases and Emerging Threats
Monday, May 20, 2019
The New York Academy of Sciences, 7 World Trade Center, 250 Greenwich St Fl 40, New York
The development of vaccines against infectious diseases, beginning a few centuries ago, have had a profound impact on human health and longevity. While there are still many serious and potentially preventable infectious diseases for which no effective vaccines are available, the biotech revolution and advances in our understanding of the immune response hold promise to address these challenges. To explore the state of the science today, this symposium will gather the world’s leaders in vaccine development. Together, they will share the latest findings that illuminate the potential and the limits of the human immune system in its response to vaccines, the challenges facing vaccine development, maternal immunizations, and the next era of vaccine technologies.
Registration
Member
By 04/19/2019
$90
After 04/19/2019
$130
Nonmember Academia, Faculty, etc.
By 04/19/2019
$180
After 04/19/2019
$260
Nonmember Corporate, Other
By 04/19/2019
$250
After 04/19/2019
$350
Nonmember Not for Profit
By 04/19/2019
$180
After 04/19/2019
$260
Nonmember Student, Undergrad, Grad, Fellow
By 04/19/2019
$100
After 04/19/2019
$145
Member Student, Post-Doc, Fellow
By 04/19/2019
$50
After 04/19/2019
$70
Member
$30
Nonmember Academia, Faculty, etc.
$65
Nonmember Corporate, Other
$85
Nonmember Not for Profit
$65
Nonmember Student, Undergrad, Grad, Fellow
$45
Member Student, Post-Doc, Fellow
$15
Earlybird Registration:
0
days
left
Speakers
James E. Crowe, Jr., MD
Vanderbilt University
Ann Ginsberg, MD, PhD**
International AIDS Vaccine Initiative
Gregory Glenn, MD
Novavax
Adrian Hill, PhD
University of Oxford
Kathrin Jansen, PhD
Pfizer
Wayne Koff, PhD
Human Vaccines Project
Sallie Permar, MD
Duke University
Bali Pulendran, PhD**
Emory University
Rino Rappuoli, PhD
GlaxoSmithKline
David Weiner, PhD
The Wistar Institute
Drew Weissman, MD, PhD
University of Pennsylvania
Ian Wilson, DPhil
The Scripps Research Institute
Organizers
Annaliesa Anderson, PhD
Pfizer
Melanie Brickman Borchard, PhD, MSc
The New York Academy of Sciences
Gregory Glenn, MD
Novavax
Wayne Koff, PhD
Human Vaccines Project
Stanley Plotkin, MD
George Zavoico, PhD
B. Riley FBR
Event Sponsors
Silver
Bronze
Academy Friend
Promotional Partners
Monday
May 20, 2019
8:10 AM
Registration, Breakfast, and Poster Setup
8:50 AM
Welcome Remarks
Speaker
Melanie Brickman Borchard, PhD, MSc
The New York Academy of Sciences
9:00 AM
Keynote Presentation: The Potential of Vaccines to Address AMR
Speaker
Padmini Srikantiah, MD, MPH
Bill & Melinda Gates Foundation
Session I: New Approaches for Understanding the Immune System for Vaccine Development
Session Chairperson
Wayne Koff, PhD, Human Vaccines Project
9:35 AM
Human Antibodies and Repertoires for Emerging Infectious Diseases
Speaker
James E. Crowe, Jr., MD
Vanderbilt University
10:00 AM
Systems Vaccinology: Probing the Immune Response to Vaccination in Humans
Speaker
Bali Pulendran, PhD **
Emory University (**not participating in webinar)
10:25 AM
Networking Coffee Break
Session II: Taking on the Big Challenges Facing Novel Vaccine Development
Session Chairperson
George Zavoico, PhD, B. Riley, FBR
10:55 AM
New Generation Malaria Vaccines
Speaker
Adrian Hill, PhD
University of Oxford
11:20 AM
TB Vaccine Development and AMR
Speaker
Ann Ginsberg, PhD, MD**
International AIDS Vaccine Initiative (**not participating in webinar)
11:45 AM
The Future of Vaccine Development
Speaker
Wayne Koff, PhD
Human Vaccines Project
Session III: Data Blitz Presentations
Session Chairperson
Melanie Brickman Borchard, PhD, MSc, The New York Academy of Sciences
12:10 PM
FluoroSpot for the Analysis of Zika and Dengue Specific and Cross-Reactive Memory B Cells
Speaker
Anuja Mathew, PhD
University of Rhode Island
12:15 PM
Protective Anti-Viral Antibodies Elicited by Vaccine that Recruit Helper T Cell Activity Induced by Prior BCG Immunization
Speaker
Tony Ng, PhD
Albert Einstein College of Medicine
12:20 PM
Networking Luncheon and Poster Session
Session IV: Vaccines to Protect Newborns: The Next Frontier
Session Chairperson
Annaliesa Anderson, PhD, Pfizer
1:45 PM
Advances in Maternal Immunization
Speaker
Kathrin Jansen, PhD
Pfizer
2:10 PM
Protecting Infants from RSV via Maternal Immunization
Speaker
Greg Glenn, MD
Novavax
2:35 PM
Next Generation Vaccines against Cytomegalovirus: We Are Half Way There
Speaker
Sallie Permar, MD, PhD
Duke University
3:00 PM
Networking Coffee Break
Session V: New Technologies for Vaccine Development
Session Chairperson
Gregory Glenn, MD, Novavax
3:30 PM
Guiding Vaccine Candidates: Antibodies That Can Neutralize Influenza and Malaria
Speaker
Ian Wilson, DPhil
The Scripps Research Institute
3:55 PM
Synthetic DNA Approaches for Difficult Infectious Disease Targets
Speaker
David Weiner, PhD
The Wistar Institute
4:20 PM
mRNA Vaccines A New Era in Vaccinology
Speaker
Drew Weissman, MD, PhD
University of Pennsylvania
4:45 PM
Transforming New Technologies into Vaccines: Genomics, Adjuvants and Self-Amplifying RNAs
Speaker
Rino Rappuoli, PhD
GlaxoSmithKline
5:10 PM
CLOSING REMARKS
Speaker
Melanie Brickman Borchard, PhD
New York Academy of Sciences
5:15 PM
Networking Reception and Poster Session
6:15 PM